CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-11 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-11 | Treco Douglas A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-11 | High Katherine A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-11 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-11 | George Simeon Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-11 | Bolzon Bradley J PhD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-02 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −779 | $66.26 | $52K | 170,747 |
| 2020-06-01 | Kulkarni Samarth Chief Executive Officer | Option exercise | +17,275 | $1.81 | $31K | 188,801 |
| 2020-06-01 | Kulkarni Samarth Chief Executive Officer | Sale | −2,400 | $63.57 | $153K | 186,401 |
| 2020-06-01 | Kulkarni Samarth Chief Executive Officer | Sale | −9,300 | $64.61 | $601K | 177,101 |
| 2020-06-01 | Kulkarni Samarth Chief Executive Officer | Sale | −5,575 | $65.26 | $364K | 171,526 |
| 2020-06-01 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −17,275 | 162,783 | ||
| 2020-05-26 | Novak Rodger President | Sale | −36,616 | $70.27 | $2.6M | 748,007 |
| 2020-05-26 | Ho Tony W Executive VP, Head of R&D | Sale | −6,100 | $70.14 | $428K | 40,905 |
| 2020-05-22 | Novak Rodger President | Sale | −13,384 | $70.01 | $937K | 784,623 |
| 2020-05-22 | Ho Tony W Executive VP, Head of R&D | Sale | −600 | $70.05 | $42K | 47,005 |
| 2020-05-20 | Kulkarni Samarth Chief Executive Officer | Option exercise | +10,693 | $1.81 | $19K | 182,219 |
| 2020-05-20 | Kulkarni Samarth Chief Executive Officer | Sale | −10,693 | $65.28 | $698K | 171,526 |
| 2020-05-20 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −10,693 | 180,058 | ||
| 2020-05-19 | Novak Rodger President | Sale | −50,000 | $65.00 | $3.3M | 798,007 |
Page 43 of 46 · 910 trades